Table 5: Norepinephrine and Vasopressin Discontinuation Sequence Outcomes.
|
|
Norepinephrine first (n=3) |
Vasopressin first (n=19) |
P-value |
|
Incidence of clinically significant hypotension – n (%) |
1 (33.3) |
15 (78.9) |
0.1688 |
|
In-hospital mortality – n (%) |
0 (0) |
12 (63.2) |
0.0779 |
|
ICU length of stay – days, median (IQR) |
14 (13.5, 30.5) |
12 (8.5, 22.5) |
0.5530 |
|
Hospital length of stay – days, median |
16 (15.5, 34) |
20 (9.5, 28) |
0.9708 |
|
Total duration of norepinephrine – hours, median (IQR) |
66 (61.25, 68) |
173 (114.1, 258.5) |
<0.001 |
|
Total duration of vasopressin – hours, median (IQR) |
67 (44.5, 70.25) |
34 (2, 51.6) |
0.4654 |
|
Total duration of vasopressors – hours, median (IQR) |
88 (77.9, 90) |
182.5 (127.25, 279.75) |
0.0018 |
Note: SD: Standard Deviation, ICU: Intensive Care Unit, IQR: Interquartile Range.